Summer Symposium 2017

Alcon

Alcon Surgical offers the industry’s most complete line of ophthalmic surgical products, enabling surgeons to achieve the best results for their patients. Our surgical portfolio includes technologies and devices for cataract, retina, glaucoma and refractive surgery, as well as advanced technology intraocular lenses (ATIOL).

Alimera Sciences

Alimera Sciences (Nasdaq: ALIM), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, manufactures ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19mg. ILUVIEN is commercially available in the US. ILUVIEN is approved in seventeen European countries and commercially available in the United Kingdom, Germany and Portugal.

Bausch + Lomb

Bausch + Lomb, a Valeant Pharmaceutical international, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing, and restoring people’s eyesight. Our businesses include ophthalmic pharmaceuticals, contact lenses, lens care products, and ophthalmic surgical devices and instruments. We develop, manufacture and market products in more than 100 countries.

Ethis

Glaukos

Glaukos® Corporation is an ophthalmic medical technology company located in Laguna Hills, California, that is dedicated to researching and developing micro-technologies to improve glaucoma therapy and has developed the iStent® Trabecular Micro-Bypass Stent. The FDA-approved iStent® is intended to reduce IOP in patients with mid-to-moderate open-angle glaucoma.

Haag-Streit USA

For over 150 years, Haag-Streit has been a leading provider of medical equipment for ophthalmologists. This experience institutes a solid groundwork for the development, design, and production of our unparalleled medical instruments and equipment. We set the standard for precision mechanics and innovative technology with an emphasis on usability and functionality.

ianTECH

Johnson & Johnson Vision

Johnson & Johnson Vision is committed to improving and restoring sight for patients worldwide. Since debuting the world’s first disposable soft contact lens in 1987, it has been helping patients see better through their world-leading ACUVUE® Brand Contact Lenses portfolio. In 2017, Johnson & Johnson invested further in eye health by expanding into cataract surgery, laser refractive surgery (LASIK) and consumer eye health. Serving more than 60 million patients a day across 103 countries, Johnson & Johnson Vision is committed to helping more people in more places improve or restore their sight. Dual headquartered in Jacksonville, Florida, and Santa Ana, California, Johnson & Johnson Vision has more than 8,400 employees worldwide.

New World Medical

Omeros

Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics. Its first FDA-approved products is Omidria® (phenyleohrine and ketotolac inhection) 1%/0.3% for use during lens replacement surgery. Omeros’ pipeline includes six clinical-stage programs, a diverse group on preclinical programs, and two drug discovery platforms.

OMIC

Pascale

Perfect Lens

Regeneron

Regeneron is a leading science and technology company that delivers life-transforming medicines for serious diseases. Founded by physician-scientists nearly 30 years ago, our science-driven approach has resulted in six FDA-approved medicines and numerous product candidates in a range of diseases, including asthma, pain, cancer and infectious diseases. In addition to the medicines, some innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human genetics sequencing efforts in the world and rapid response technologies being used for global good.

The Allergan Foundation

WIN (Women Innovating Now)

The WIN mission is to inspire, develop and empower a diverse community of women as leaders. Our vision is to cultivate an inclusive environment where men and women work together to develop and inspire a future generation of leaders while driving business results in a diverse, dynamic patient-centric marketplace.

Zeiss

ZEISS offers complete solutions to diagnose, manage and treat ophthalmic disease. The comprehensive ZEISS portfolio is designed to meet the demands of eye care professionals in glaucoma, retina, comprehensive, cataract and refractive specialties. With additional solutions in data management, ZEISS products help doctors to deliver the best possible patient care.